bio-protac-degraders — independently scanned and version-tracked by SaferSkills.
SaferSkills independently audited bio-protac-degraders (Agent Skill) and scored it 100/100 (green). The audit ran 55 deterministic rules across Security, Supply Chain, Maintenance, Transparency, and Community; it found 0 high-severity and 0 lower-severity findings. The full rule-by-rule trace and per-finding evidence are below. Free, methodology-open.
Findings & checks · 0 flagged
Every scanned point with the score it earned and what moved between them.
First recorded scan — no prior version to compare against.
The primary manifest — the file an agent reads to learn what this artifact does.
Reference examples tested with: PRosettaC (web service), DeepTernary 1.0+, AlphaFold3 (constraints-enabled), Boltz-1 / Boltz-2, RDKit 2024.09+, OpenMM 8.1+ (for ternary MD).
Before using code patterns, verify installed versions match. If versions differ:
pip show <package> then help(module.function) to check signaturesIf code throws ImportError, AttributeError, or TypeError, introspect the installed package and adapt the example to match the actual API rather than retrying.
Design bifunctional molecules (PROTACs) that recruit an E3 ubiquitin ligase to a target protein, inducing target ubiquitination and proteasomal degradation. PROTACs differ from traditional drugs: a stable ternary complex (target + PROTAC + E3) is required, not just target binding. The PROTAC field exploded post-2020 with clinical successes (ARV-471 estrogen-receptor degrader, ARV-110 androgen-receptor degrader). Postdoc-grade PROTAC design balances target ligand binding, E3 ligand binding, linker geometry (length, rigidity, chemistry), cooperativity (positive = ternary stable; negative = hook effect), and cell permeability (PROTACs are 800-1500 Da, often Lipinski-violating).
For target ligand design, see chemoinformatics/virtual-screening and chemoinformatics/admet-prediction. For linker-only enumeration, see chemoinformatics/reaction-enumeration. For generative linker design, see chemoinformatics/generative-design.
| E3 ligase | Ligand series | Best at | Limitations |
|---|---|---|---|
| VHL | VL-269 (Salami 2018) | Surface-exposed targets | Tissue-restricted expression |
| CRBN (cereblon) | thalidomide, pomalidomide | Broad tissue expression | Off-target neosubstrates (IKZF1, SALL4) |
| IAP (XIAP, cIAP1) | SMAC mimetics (LCL161, etc.) | Apoptotic / IAP targets | Limited target scope |
| MDM2 | nutlin / idasanutlin | TP53 pathway | Limited target diversity |
| KEAP1 | DDB1-DCAF15-Keap1 | NRF2 pathway | Specialized use |
| RNF114 | EN450 | Newer; under exploration | Limited tooling |
| RNF4 | EN450-RNF4 | Newer; growing | Limited tooling |
| Cyclin E - SKP2 | New ligands emerging | Targeted cancers | Discovery-phase |
Decision: For first-generation PROTAC, CRBN (cereblon) is the most-developed (thalidomide-derived; broad tissue distribution). VHL is second-most-developed (more selective; tissue-restricted). For specialty targets, consider IAP / MDM2.
Linkers tune ternary complex geometry and stability:
| Property | Range | Effect |
|---|---|---|
| Linker length | 8-30 atoms | Critical; geometry-dependent |
| Linker rigidity | Flexible (PEG) vs rigid (piperazine, pyridine) | Higher rigidity often reduces entropy penalty |
| Linker chemistry | PEG, alkyl, piperazine, triazole, ether, amide | PEG common; rigid for tighter binding |
| Click chemistry compatibility | Triazole compatible | Easy synthesis |
| MW range | PROTAC 800-1500 Da | Lipinski-violating but accepted |
| Polar atoms | 1-5 per linker | Permeability vs solubility balance |
Critical: The "Goldilocks linker length" is target-specific. Too short = ternary clash; too long = ternary entropy too high. Typically 12-20 atoms for surface-exposed targets.
| Goal | E3 / linker | Tools |
|---|---|---|
| First-generation PROTAC, surface-exposed target | CRBN + PEG linker (10-15 atoms) | PRosettaC for ternary prediction |
| Selective degrader (avoid off-target) | VHL + rigid linker | PRosettaC + cellular validation |
| BTK / IAP family targets | IAP-based PROTAC | Standard pipelines |
| Targeted protein degradation in cancer | CRBN or VHL | Standard clinical track |
| Novel target, no cryptic | Multiple E3 / linker variants | Combinatorial design + PRosettaC |
| Molecular glue (non-PROTAC) | CRBN-based | Distinct mechanism; pomalidomide-class |
| Optimize cooperativity (alpha > 1) | PRosettaC iterative; experimental | Ternary MD + ITC |
| Cell-active candidate | Standard development | PK + degradation cellular assays |
| Tool | Approach | Strength | Fails when |
|---|---|---|---|
| PRosettaC | Rosetta + REMD on PROTAC | Mature; reliable | License Rosetta |
| DeepTernary | Equivariant deep learning | Fast; SE(3) | OOD chemistry |
| AlphaFold3 + constraints | Foundation model + restraints | High accuracy | Public access limited |
| Boltz-1 / Boltz-2 + constraints | Foundation model | Fast; flexible | Limited PROTAC training |
| HADDOCK | Restraint-based MD | Veteran | Manual restraint specification |
| Schrodinger Phase + Glide | Commercial | Production-ready | License cost |
Decision: For first-pass ternary modeling, PRosettaC is the standard. For prospective generative + ranking, AlphaFold3 with constraints (if access) or Boltz-1/2 (open). DeepTernary is a fast alternative when validated against benchmark.
Cooperativity quantifies how the ternary complex stabilizes (or destabilizes) the binary binding:
alpha = (Kd_binary,target) / (Kd_ternary,target)Positive cooperativity (alpha > 2-3) is the gold standard for PROTAC design. It means the ternary complex is stabilized by protein-protein interactions induced by the linker geometry.
Measure with ITC (isothermal titration calorimetry) or SPR/BLI titrations of binary vs ternary.
In cellular assays:
| Property | Good value | Notes |
|---|---|---|
| DC50 | < 100 nM | Clinically meaningful |
| Dmax | > 80% | Sufficient depletion for phenotype |
| Hook effect | < 10x range | Linear dose-response over 100x |
| Hook concentration | typically > 10x DC50 | Above which binary complexes dominate |
Hook effect: at high PROTAC concentrations, binary complexes (PROTAC-target alone, PROTAC-E3 alone) dominate, and ternary complex formation drops. Dose-response curves are bell-shaped.
Goal: Predict 3D structure of target-PROTAC-E3 ternary complex.
Approach:
# Pseudo-code workflow
def predict_ternary(target_pdb, target_ligand_sdf,
e3_pdb, e3_ligand_sdf, linker_smiles):
# 1. Place binary complexes in same coordinate frame
# 2. Enumerate linker connectivity from target-ligand exit vector to e3-ligand entry vector
# 3. Score by total linker length, RMSD to expected geometry
# 4. Minimize with restraint MD (5-20 ns)
return ternary_posesFor production workflow, use PRosettaC web service or AlphaFold3 with chain-chain constraint inputs.
from rdkit import Chem
from rdkit.Chem import AllChem
def linker_distance(target_pose, e3_pose, target_ligand_smi, e3_ligand_smi, n_conf=20):
"""
Compute distance between target-ligand exit vector and e3-ligand entry vector.
Linker must span this distance with flexibility.
"""
# Place target + e3 in same frame (from PRosettaC or HADDOCK)
# Find target-ligand attachment atom and e3-ligand attachment atom
# Compute distance
pass
def required_linker_atoms(distance_A, rigidity='flexible'):
"""
Estimate atoms needed in linker to span distance.
Flexible (CC bond ~1.5 A) -> distance / 1.5
Rigid (sp2 C-C ~1.4 A) -> distance / 1.4 + curvature factor
"""
if rigidity == 'flexible':
return int(distance_A / 1.4 * 1.2) # 20% slack
return int(distance_A / 1.4 * 1.5)Combine REINVENT 4 linker mode with ternary prediction:
[run]
type = "linker"
prior_file = "priors/linker.prior"
[parameters]
input_smiles = "[*]NC(=O)..." # Target ligand with attachment
linker_target_smiles = "[*]NC(=O)..." # E3 ligand with attachment
n_steps = 200
[scoring_function.components]
type = "linker_length"
weight = 0.3
target_atoms = 14
type = "ternary_score"
weight = 0.5
ternary_predictor = "deepternary" # API call
type = "qed"
weight = 0.2REINVENT 4 supports linker generation; scoring needs ternary prediction (currently expensive). Modern best practice: combinatorial enumeration with PRosettaC scoring.
Trigger: Target's known binding mode incompatible with E3 ligase orientation.
Mechanism: PRosettaC samples linker conformations; can't bridge if E3 surface is occluded.
Symptom: Low ternary complex scores; high RMSD across replicates.
Fix: Try different E3 (CRBN vs VHL); use ARV-110 / ARV-471 family templates.
Trigger: Target ligand or E3 ligand outside training distribution.
Mechanism: DeepTernary learns from TernaryDB; novel chemotypes extrapolate.
Symptom: Predicted ternary complex unrealistic.
Fix: Validate against PRosettaC; use as fast screening, validate top-N with PRosettaC.
Trigger: PROTAC linker too long; binary preferred energetically.
Mechanism: Negative cooperativity at low concentration; ternary unstable.
Symptom: Dose-response curve narrow; DC50 close to hook.
Fix: Shorter linker; increase cooperativity by adding protein-protein contact-promoting motifs.
Trigger: PROTAC > 1200 Da, polar, high TPSA.
Mechanism: Lipinski violations; permeability bottleneck.
Symptom: Cellular DC50 1000x worse than biochemical DC50.
Fix: Optimize linker for amphipathic profile; PROTACs often violate Ro5 but successful ones are < 1200 Da with < 130 TPSA.
Trigger: Computing linker length from binary models without ternary refinement.
Mechanism: Binary structures don't capture ternary geometry.
Symptom: PROTACs synthesized at wrong linker length; no degradation.
Fix: Use PRosettaC-refined ternary distance; enumerate ±3 atoms around predicted optimal.
Trigger: Designing as PROTAC when target lacks defined ligand.
Mechanism: Molecular glues (like thalidomide for IKZF1) don't have target ligand component.
Symptom: Design too rigid; no degradation despite ternary prediction.
Fix: For targets without known ligand, consider molecular glue discovery instead.
| Aspect | PRosettaC | AlphaFold3 |
|---|---|---|
| Approach | REMD on linker + binary | Foundation model + restraints |
| Accuracy | High (validated benchmark) | Limited PROTAC data in training |
| Speed | Hours per ternary | Minutes |
| Open access | Yes (web service) | Public API, limited usage |
| Customization | Limited | Constraint flexibility |
| Decision | Standard for PROTAC | Promising; validate |
For PROTAC design, PRosettaC + ITC/SPR experimental validation is the current best practice.
| Symptom | Cause | Fix |
|---|---|---|
| PRosettaC fails to converge | Linker too long or E3 surface buried | Try different E3; check binary structure quality |
| DeepTernary returns clashing pose | OOD chemotype | Use PRosettaC for refinement |
| AlphaFold3 ternary unrealistic | Constraint not specified properly | Use chain-chain distance constraints |
| PROTAC cell-active but biochemical degradation poor | Off-target neosubstrate (CRBN-IKZF) | Confirm target specificity via mass spec |
| Hook effect at low PROTAC concentration | Negative cooperativity | Optimize linker geometry |
| Synthesis too complex | Linker via 5+ step | Use click chemistry (triazole linker) |
| MW > 1500 Da issue | Excessive linker | Reduce linker length; rigid linker |
~30 seconds. Free. No account. Every finding cites a rule and a line of evidence.